Report : A-Z HCD items in Formulary 25/04/2025 17:13:40

[Back]

Section Status BlueTeq Name 06.06.01 Formulary Abaloparatide  10.01.03 Formulary Abatacept Orencia® 13.05.03 Formulary Abrocitinib Cibinqo ® 01.05.03 Formulary Adalimumab  10.01.03 Formulary Adalimumab Biosimilars avaliable 11.08.02 Formulary Adalimumab  13.05.03 Formulary Adalimumab Biosimilars avaliable 11.08.02 Formulary Aflibercept Eylea® 08.02.03 Formulary Alemtuzumab Lemtrada® 02.12 Formulary Alirocumab Praluent® 13.05.01 Formulary Alitretinoin Toctino® 10.01.03 Formulary Apremilast  13.05.03 Formulary Apremilast Otezla® 09.08.01 Formulary Asfotase alfa Strensiq® 04.07.04.02 Formulary Atogepant Aquipta® 09.08.01 Formulary Avalglucosidase alfa Nexviadyme ® 09.01.04 Formulary Avatrombopag Doptelet® 10.01.03 Formulary Baricitinib Olumiant® 05.01.09 Formulary Bedaquiline  11.08.02 Formulary Bevacizumab gamma  10.01.03 Formulary Bimekizumab Bimzelx® 13.05.03 Formulary Brodalumab Kyntheum® 11.08.02 Formulary Brolucizumab  Beovu® 05.03.03 Formulary Bulevirtide  HEPCLUDEX® 06.06.02 Formulary Burosumab Crysvita® 05.03.01 Formulary Cabotegravir  Vocabria® 09.01.04 Formulary Caplacizumab  Cablivi ® 10.01.03 Formulary Certolizumab Pegol Cimzia® 09.01.03 Formulary Crovalimab Piasky® 09.01.03 Formulary Danicopan  05.01.09 Formulary Delamanid  13.05.03 Formulary Deucravacitinib SOTYKTU 11.04.01 Formulary Dexamethasone intravitreal implant Ozurdex® 13.05.02 Formulary Dimethyl Fumarate Skilarence® 13.05.03 Formulary Dupilumab Dupixent® 08.01.05 Formulary Durvalumab  09.08.01 Formulary Eladocagene exuparvovec Upstaza® 05.03.03.02 Formulary Elbasvir with grazoprevir  Zepatier® 09.01.04 Formulary Eltrombopag Revolade® 09.08.01 Formulary Eplontersen Wainzua® 04.07.04.02 Formulary Eptinezumab Vyepti® 04.07.04.02 Formulary Erenumab Aimovig® 10.01.03 Formulary Etanercept Biosimilars avaliable 13.05.03 Formulary Etanercept Biosimilars avaliable 02.12 Formulary Evinacumab Evkeeza® 02.12 Formulary Evolocumab Repatha® 11.08.02 Formulary Faricimab Vabysmo ® 04.08.01 Formulary Fenfluramine  Fintepla® 01.05.03 Formulary Filgotinib  10.01.03 Formulary Filgotinib  Jyseleca® 11.04.01 Formulary Fluocinolone intravitreal implant Iluvien® 09.01.04 Formulary Fostamatinib  TAVLESSE ® 05.03.01 Formulary Fostemsavir Rukobia® 04.07.04.02 Formulary Fremanezumab Ajovy® 04.07.04.02 Formulary Galcanezumab  Emgality® 05.03.03.02 Formulary Glecaprevir with pibrentasvir Maviret® 01.05.03 Formulary Golimumab  10.01.03 Formulary Golimumab Simponi® 13.05.03 Formulary Guselkumab Tremfya® 01.05.03 Formulary Infliximab  08.01 Formulary Infliximab  10.01.03 Formulary Infliximab Biosimilars avaliable 13.05.03 Formulary Infliximab Biosimilars avaliable 06.01.01.03 Formulary Insulin pumps  09.01.03 Formulary Iptacopan Fabhalta® 03.07 Formulary Ivacaftor–Tezacaftor–Elexacaftor Kaftrio® 10.01.03 Formulary Ixekizumab  13.05.02 Formulary Ixekizumab  Taltz® 08.03.04.03 Formulary Lanreotide  05.03.03.02 Formulary Ledipasvir and Sofosbuvir Harvoni® 08.01.05 Formulary Leniolisib phosphate Joenja® 05.03.02.02 Formulary Letermovir Prevymis® 04.09.01 Formulary Levodopa-Carbidopa- Entacapone Intestinal Gel (LECIG)  04.09.01 Formulary Levodopa-Carbidopa Intestinal Gel (LCIG)  03.07 Formulary Lumacaftor–Ivacaftor Orkambi® 09.01.04 Formulary Lusutrombopag Mulpleo® 05.03.02.02 Formulary Maribavir Livtencity® 03.04.02 Formulary Mepolizumab   01.05.03 Formulary Mirikizumab  08.02.03 Formulary Ocrelizumab Ocrevus® 08.02.03 Formulary Ofatumumab Arzerra® 08.03.04.01 Formulary Olaparib  13.05.03 Formulary Omalizumab  01.05.03 Formulary Ozanimod  08.02 Formulary Ozanimod Zeposia® 05.03.05 Formulary Palivizumab Synagis® 08.02.04 Formulary Peginterferon Alfa Pegasys® 06.05 Formulary Pegvisomant  05.01.09 Formulary Pretomanid  11.08.02 Formulary Ranibizumab  09.01.03 Formulary Ravulizumab Ultomiris® 03.04.02 Formulary Reslizumab  04.07.04.02 Formulary Rimegepant Vydura 01.05.03 Formulary Risankizumab Skyrizi® 10.01.03 Formulary Risankizumab Skyrizi® 13.05.03 Formulary Risankizumab Skyrizi® 13.05.03 Formulary Ritlecitinib  08.02.03 Formulary Rituximab  10.01.03 Formulary Rituximab (rheumatology) Biosimilars avaliable 09.01.04 Formulary Romiplostim Nplate® 08.02.04 Formulary Ropeginterferon Alfa-2b Besremi® 08.02.02 Formulary Ruxolitinib Jakavi® 10.01.03 Formulary Sarilumab Kevzara® 10.01.03 Formulary Secukinumab  13.05.03 Formulary Secukinumab Cosentyx® 05.03.03.02 Formulary Sofosbuvir and Velpatasvir  Epclusa® 05.03.03.02 Formulary Sofosbuvir with Velpatasvir and Voxilaprevir Vosevi® 04.04 Formulary Solriamfetol hydrochloride Sunosi® 06.05.01 Formulary Somatrogon Ngenla® 04.12 Formulary Tafamidis  03.07 Formulary Tezacaftor–Ivacaftor Symkevi® 13.05.03 Formulary Tildrakizumab Ilumetri® 10.01.03 Formulary Tocilizumab Biosimilars avaliable 01.05.03 Formulary Tofacitinib  10.01.03 Formulary Tofacitinib Xeljanz® 06.05.02 Formulary Tolvaptan  08.02.03 Formulary Ublituximab Briumvi® 01.05.03 Formulary Upadacitinib  Rinvoq ® 10.01.03 Formulary Upadacitinib  Rinvoq ® 13.05.03 Formulary Upadacitinib  Rinvoq ® 01.05.03 Formulary Ustekinumab  10.01.03 Formulary Ustekinumab  13.05.03 Formulary Ustekinumab Stelara® 09.01.03 Formulary Vadadustat Vafseo® 10.02 Formulary Vamorolone Agamree® 08.01 Formulary Vedolizumab Entyvio® 11.11 Formulary Voretigene Neparvovec Luxturna® 09.08.01 Formulary Vutrisiran Amvuttra ®

Lancashire and South Cumbria